Atomo NewsGet the app

Get the latest Science News and Discoveries

Insilico Medicine and Taigen achieves license agreement to develop and commercialize AI-driven PHD inhibitor for anemia of Chronic Kidney Disease (CKD) - EurekAlert!


Comprehensive up-to-date news coverage, aggregated from sources all over the world by Google News.

None

Get the Android app

Or read this on Eureka Alert

Read more on:

Photo of PhD

PhD

Photo of Anemia

Anemia

Photo of Insilico Medicine

Insilico Medicine

Related news:

News photo

Insilico Medicine unveils winter edition of Pharma.AI, accelerating the path to pharmaceutical superintelligence - EurekAlert!

News photo

Announcing the 2025 Glenn Foundation for Medical Research Discovery Awards: Christina Camell, PhD (University of Minnesota) and Elaine Fuchs, PhD (The Rockefeller University) - EurekAlert!

News photo

Insilico Medicine and Atossa Therapeutics publish AI-driven study in Nature's Scientific Reports identifying (Z)-endoxifen as a potential therapeutic candidate for glioblastoma - EurekAlert!

« Cleveland Clinic presents final results of phase 1 clinical trial of preventive breast cancer vaccine study - EurekAlert!
Ultra-hot lava world has thick atmosphere, upending expectations - EurekAlert! »